Compumedics

Compumedics EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Compumedics (CMP.AX) as of Oct 16, 2026 is 1.79 M AUD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 714,000.00 AUD — a change of 150.28% (higher).

EBITDA

1.79 MAUD

YoY

150.28%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Compumedics is 2026 1.79 M AUD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Compumedics was 2025 714,000.00 AUD. It decreases by 150.28% higher compared to the previous year.

The Compumedics EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
5.01 M AUD
Jan 1, 2020
-756,000.00 AUD
Jan 1, 2021
1.11 M AUD
Jan 1, 2022
538,000.00 AUD
Jan 1, 2023
-6.07 M AUD
Jan 1, 2024
1.22 M AUD
Jan 1, 2025
714,000.00 AUD
Jan 1, 2026
1.79 M AUD
The Compumedics EBITDA history
YEAREBITDAYoY
1.79 MAUD+150.28%
714,000.00AUD-41.43%
1.22 MAUD-120.09%
-6.07 MAUD-1,227.70%
538,000.00AUD-51.36%
1.11 MAUD-246.30%
-756,000.00AUD-115.09%
5.01 MAUD+63.20%
3.07 MAUD+116.45%
1.42 MAUD-55.84%
3.21 MAUD+19.55%
2.69 MAUD+69.68%
1.58 MAUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Compumedics Stock analysis

What does Compumedics do? Compumedics Ltd., headquartered in Melbourne, Australia, operates in the Health Care sector, specializing in the research, development, manufacture, and distribution of medical equipment. The company employs 135 full-time staff and serves global markets across the Americas, Australia, Asia Pacific, and Europe and the Middle East. Its product portfolio includes sleep diagnostic systems, clinical EEG systems, brain monitoring solutions, ultrasonic blood-flow systems, and technical support services. Key offerings encompass Somfit/Somfit Pro, Grael 4K PSG:EEG, and Compumedics Neuroscan for neurology applications and brain research technologies. Compumedics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compumedics stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Compumedics is 1.79 M AUD in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Compumedics changed from 714,000.00 AUD to 1.79 M AUD, representing a 150.28% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Compumedics since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Compumedics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Compumedics

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Compumedics